Vis enkel innførsel

dc.contributor.authorNæss, Synnøve
dc.contributor.authorMarkhus, Maria Wik
dc.contributor.authorStrand, Tor Arne
dc.contributor.authorKjellevold, Marian
dc.contributor.authorDahl, Lisbeth
dc.contributor.authorStokland, Ann-Elin Meling
dc.contributor.authorNedrebø, Bjørn Gunnar
dc.contributor.authorAakre, Inger
dc.date.accessioned2022-01-18T08:55:31Z
dc.date.available2022-01-18T08:55:31Z
dc.date.created2021-11-11T12:14:31Z
dc.date.issued2021
dc.identifier.citationJournal of Nutrition. 2021, 151 (10), 3187-3196.
dc.identifier.issn0022-3166
dc.identifier.urihttps://hdl.handle.net/11250/2837806
dc.description.abstractBackground: Whereas the adverse effects of severe iodine deficiency during pregnancy are well documented, the effects of mild-to-moderate deficiency are not well established. Objectives: We aimed to explore whether iodine nutrition and timing of iodine supplement initiation are associated with thyroid function in pregnant and postpartum women. Methods: In this cohort study, 137 pregnant women were enrolled and followed up at gestational weeks (GWs) 18 and 36, and 3 and 6 mo postpartum. Thyroid function tests [thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4)], urinary iodine and creatinine concentration (UIC:Cr), and iodine intake (including iodine supplement use) were measured at each time point. The associations between thyroid hormone concentrations and UIC:Cr, iodine intakes, and iodine supplement use were estimated using multiple generalized estimating equation models. Results: The median UIC at GW18 was 94 μg/L, indicating mild-to-moderate iodine deficiency. UIC:Cr (β; 95% CI) per 100 μg/g was negatively associated with fT3 (-0.191; -0.331, -0.051) and fT4 (-0.756; -1.372, -0.141) concentrations. Iodine intake (β; 95% CI) per 100 μg/d was positively associated with TSH (0.099; 0.022, 0.177), and negatively associated with fT3 (-0.084; -0.0141, -0.027) and fT4 (-0.390; -0.599, -0.182) concentrations. Compared with no use of supplement, those initiating an iodine-containing supplement prepregnancy and continuing through pregnancy had lower TSH (estimated means) (1.35 compared with 1.68 mIU/L, P = 0.021), and higher fT3 (4.48 compared with 4.28 pmol/L, P = 0.035) and fT4 (15.2 compared with 14.4 pmol/L, P = 0.024) concentrations. Conclusions: Lower iodine availability during pregnancy and postpartum was associated with lower TSH, and higher fT3 and fT4 concentrations. The use of an iodine-containing supplement that was initiated prepregnancy and continuing through pregnancy was associated with lower TSH, and higher fT3 and fT4 concentrations, which may suggest improved thyroid function. These findings support the notion that optimization of iodine intake should start before pregnancy.This trial was registered at clinicaltrials.gov as NCT02610959. Keywords: iodine; iodine deficiency; iodine supplementation; pregnancy; thyroid hormones. © The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
dc.language.isoeng
dc.relation.urihttps://watermark.silverchair.com/nxab224.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAtUwggLRBgkqhkiG9w0BBwagggLCMIICvgIBADCCArcGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMvQhXRNvIchLZAI_3
dc.titleIodine nutrition and iodine supplement initiation in association with thyroid function in mildly-to-moderately iodine-deficient pregnant and postpartum women
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.description.versionpublishedVersion
dc.source.pagenumber3187-3196
dc.source.volume151
dc.source.journalJournal of Nutrition
dc.source.issue10
dc.identifier.doi10.1093/jn/nxab224
dc.identifier.cristin1953643
dc.relation.projectHavforskningsinstituttet: 901038
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel